1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsACL Innovation Lab is sponsored by National Council on Aging (NCOA) for the Administration for Community Living (ACL). The ACL Innovation Lab awards grants to organizations to test falls prevention activities, demonstrating how flexible, adaptable, and relevant approaches can reduce falls risks among older adults.
Get alerted about grants like this
Save a search for “National Council on Aging (NCOA) for the Administration for Community Living (ACL)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Not-for-profit organizations, including nonprofit housing providers. Confirm the full requirements in the official notice before applying.
The current listing shows up to $290,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for ACL Innovation Lab are due May 31, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
ACL Innovation Lab is funded by National Council on Aging (NCOA) for the Administration for Community Living (ACL). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article